The membrane as a target for controlling hypervirulent Clostridium difficile infections

Author： Wu Xiaoqian Cherian Philip T. Lee Richard E. Hurdle Julian G.

ISSN： 1460-2091

Source： Journal of Antimicrobial Chemotherapy, Vol.68, Iss.4, 2013-04, pp. : 806-815

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low Risk of Clostridium difficile Infections in Hospitalized Patients with Inflammatory Bowel Disease in a German Tertiary Referral Center

Digestion, Vol. 84, Iss. 3, 2011-06 ,pp. : 187-192

Karger

Access to resources Recommend Favorite

Clostridium Difficile Infection Following Chemotherapy

Recent Patents on Anti-Infective Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

Review of medical and surgical management of Clostridium difficile infection

By Faris B.

Techniques in Coloproctology, Vol. 14, Iss. 2, 2010-06 ,pp. : 97-105

Springer Publishing Company

Access to resources Recommend Favorite

Fidaxomicin inhibits toxin production in Clostridium difficile

By Babakhani Farah Bouillaut Laurent Sears Pamela Sims Carlee Gomez Abraham Sonenshein Abraham L.

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 515-522

Oxford University Press

Access to resources Recommend Favorite

Editorial Commentary : Clostridium difficile in Children: Colonization and Consequences

By El Feghaly Rana E. Tarr Phillip I.

Clinical Infectious Diseases, Vol. 57, Iss. 1, 2013-07 ,pp. : 9-12

Oxford University Press

Access to resources Recommend Favorite